Dymicron Granted IDE Approval for Triadyme-C Artificial Disc

Dymicron’s Triadyme-C achieves critical milestone to begin U.S. IDE clinical trial OREM, Utah, July 10, 2025 /PRNewswire/ — Dymicron®, a privately held medical device company pioneering advanced spinal technologies, today announced that the United States (U.S.) Food and Drug…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks